CLUN19026 / LUNGMAP / Megan Baumgart
Basic Study Information
Purpose:Location: University of Rochester
This screening and multi-sub-study randomized phase II/III trial will establish a
method for genomic screening of similar large cancer populations followed by assigning
and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP).
The type of cancer trait (biomarker) will determine to which sub-study, within this
protocol, a participant will be assigned to compare new targeted cancer therapy, designed
to block the growth and spread of cancer, or combinations to standard of care therapy
with the ultimate goal of being able to approve new targeted therapies in this setting.
In addition, the protocol includes non-match sub-studies which will include all screened
patients not eligible for any of the biomarker-driven sub-studies.
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search